To validate the potential of the phosphorylation of Rb at S249 (Phospho-Rb S249) in identifying aggressive prostate cancer (PCa), we conducted the immunohistochemistry (IHC) of PCa tumor microarrays (TMAs). This evidence concerns the gene RB1 and prostate carcinoma.